Journal of psychiatric research
Journal
Overview
publication venue for
-
Different pharmacokinetics of lithium orotate inform why it is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania..
164.
2023
-
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial..
157.
2022
-
Risk of suicide attempts and self-harm after 1.4 million general medical hospitalizations of men with mental illness..
157.
2022
-
Early response to cognitive behavioral therapy for body dysmorphic disorder as a predictor of outcomes..
152.
2022
-
Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries..
144.
2021
-
Brain morphometry in adults with gambling disorder..
141.
2021
-
Clinical profiles of college student patients in a psychiatric hospital..
140.
2021
-
Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome..
140.
2021
-
Mental health mediators of subjective cognitive concerns among World Trade Center responders..
140.
2021
-
Association of working memory and elevated overnight urinary norepinephrine in patients with schizophrenia..
137.
2021
-
Bifactor model of cognition in schizophrenia: Evidence for general and specific abilities..
136.
2021
-
Using weak supervision and deep learning to classify clinical notes for identification of current suicidal ideation..
136.
2021
-
Associations among gonadal hormone, triglycerides and cognitive decline in female patients with major depressive disorders.
2020
-
Capturing behavioral indicators of persecutory ideation using mobile technology..
116.
2019
-
Empirical evidence of the effect of personality pathology on the outcome of panic disorder..
107.
2018
-
Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial..
97.
2017
-
Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups..
97.
2017
-
A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment (PreMCI) and the relationship to biological markers of Alzheimer's disease..
96.
2017
-
The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression..
82.
2016
-
Evidence for alterations of the glial syncytial function in major depressive disorder..
72.
2015
-
A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia..
68.
2015
-
Predicting placebo response in adolescents with major depressive disorder: The Adolescent Placebo Impact Composite Score (APICS)..
68.
2015
-
The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment..
61.
2014
-
Association between binge eating disorder and changes in cognitive functioning following bariatric surgery..
59.
2014
-
The role of leptin, melanocortin, and neurotrophin system genes on body weight in anorexia nervosa and bulimia nervosa..
55.
2014
-
Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol..
51.
2013
-
Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex..
47.
2013
-
Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder..
47.
2013
-
Factors associated with recovery from anorexia nervosa..
47.
2013
-
Activation of brain areas concerned with social cognition during moral decisions is abnormal in schizophrenia patients and unaffected siblings..
47.
2013
-
Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder..
47.
2012
-
Dysfunctional attitudes as a moderator of pharmacotherapy and psychotherapy for chronic depression..
47.
2012
-
Comparison of metabolic profiles of acutely ill and short-term weight recovered patients with anorexia nervosa reveals alterations of 33 out of 163 metabolites..
46.
2012
-
A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder..
46.
2012
-
Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study..
45.
2011
-
Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial..
45.
2011
-
The role and interpretation of pilot studies in clinical research..
45.
2010
-
The latent structure of alcohol use pathology in an epidemiological sample..
45.
2010
-
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression..
45.
2010
-
Personality traits and medical outcome of cardiac illness..
44.
2010
-
Chronic pain and major depressive disorder in the general population..
44.
2010
-
Latent structure of intermittent explosive disorder in an epidemiological sample..
44.
2010
-
A pilot study of the phase angle between cortisol and melatonin in major depression - a potential biomarker?.
44.
2009
-
Does improving mood in depressed patients alter factors that may affect cardiovascular disease risk?.
43.
2009
-
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment..
43.
2009
-
Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression..
43.
2008
-
Functional impairment in body dysmorphic disorder: a prospective, follow-up study..
42.
2008
-
Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia..
40.
2005
-
Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness..
40.
2005
-
Detecting psychotic major depression using psychiatric rating scales..
40.
2005
-
Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions..
40.
2005
-
Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder..
39.
2005
-
Age and disease severity predict choice of atypical neuroleptic: a signal detection approach to physicians' prescribing decisions..
37.
2003
-
Effects of comorbid diagnoses on sleep disturbance in PTSD..
36.
2002
-
Hypercortisolemia decreases dexamethasone half-life in rabbit..
36.
2002
-
Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment..
36.
2002
-
Gate questions in psychiatric interviewing: the case of suicide assessment..
35.
2001
-
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain..
34.
2000
-
Cost effectiveness of screening for clinical trials by research assistants versus senior investigators..
33.
1999
-
Benzodiazepines: therapeutic, biological, and psychosocial issues..
24 Suppl 2.
1990
-
Reliability of self-reported age at onset of major depression..
23.
1989
-
A corticosteroid/dopamine hypothesis for psychotic depression and related states..
19.
1985
-
Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data..
19.
1985
-
Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions..
19.
1985
-
Dexamethasone increases plasma free dopamine in man..
18.
1984
-
Genetic differences in mechanisms involving neuroregulators..
11.
1974
-
Biomarkers and classifications..
41.
2007
-
PTSD and lower respiratory symptoms: A systematic review of longitudinal associations in early 9/11 World Trade Center responders.
2023
-
A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude.
2019
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)